Literature DB >> 26172964

Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome.

Decio Armanini1, Chiara Sabbadin1, Gabriella Donà2, Alessandra Andrisani3, Guido Ambrosini3, Luciana Bordin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26172964      PMCID： PMC8032066          DOI： 10.1111/jch.12613

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  14 in total

1.  Preeclampsia: the role of aldosterone in hypertension and inflammation.

Authors:  Decio Armanini
Journal:  Hypertension       Date:  2012-04-23       Impact factor: 10.190

Review 2.  Clinical practice. Chronic hypertension in pregnancy.

Authors:  Ellen W Seely; Jeffrey Ecker
Journal:  N Engl J Med       Date:  2011-08-04       Impact factor: 91.245

3.  Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; W Futterweit; A Dobrjansky
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

4.  Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

Authors:  D S Geller; A Farhi; N Pinkerton; M Fradley; M Moritz; A Spitzer; G Meinke; F T Tsai; P B Sigler; R P Lifton
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

5.  Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.

Authors:  Gabriella Donà; Chiara Sabbadin; Cristina Fiore; Marcantonio Bragadin; Francesco L Giorgino; Eugenio Ragazzi; Giulio Clari; Luciana Bordin; Decio Armanini
Journal:  Eur J Endocrinol       Date:  2012-01-05       Impact factor: 6.664

Review 6.  11beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.

Authors:  Maja Causevic; Markus Mohaupt
Journal:  Mol Aspects Med       Date:  2007-04-27

7.  Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women.

Authors:  Natasa Z Dordević; Goran M Babić; Snezana D Marković; Branka I Ognjanović; Andras S Stajn; Radoslav V Zikić; Zorica S Saicić
Journal:  Reprod Toxicol       Date:  2007-11-17       Impact factor: 3.143

8.  Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies.

Authors:  Corrie Macdonald-Wallis; Debbie A Lawlor; Abigail Fraser; Margaret May; Scott M Nelson; Kate Tilling
Journal:  Hypertension       Date:  2012-04-23       Impact factor: 10.190

9.  Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.

Authors:  Arrigo F G Cicero; Daniela Degli Esposti; Vincenzo Immordino; Martino Morbini; Cristina Baronio; Martina Rosticci; Claudio Borghi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

Review 10.  Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Jun Z Qin; Li H Pang; Mu J Li; Xiao J Fan; Ru D Huang; Hong Y Chen
Journal:  Reprod Biol Endocrinol       Date:  2013-06-26       Impact factor: 5.211
View more
  5 in total

1.  Hypertension in pregnancy: Role of body mass index, insulin resistance, aldosterone, and calcium homeostasis.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Gabriella Donà; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-16       Impact factor: 3.738

2.  Uterine fibroids and risk of hypertension: Implication of inflammation and a possible role of the renin-angiotensin-aldosterone system.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Luciana Bordin; Loris Marin; Alessandra Andrisani; Guido Ambrosini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

3.  Sodium intake, sodium excretion, and cardiovascular risk: involvement of genetic, hormonal, and epigenetic factors.

Authors:  Decio Armanini; Luciana Bordin; Gabriella Donà; Raffaele Pezzani; Guido Ambrosini; Alessandra Andrisani; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07       Impact factor: 3.738

4.  Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.

Authors:  Chiara Sabbadin; Filippo Ceccato; Eugenio Ragazzi; Marco Boscaro; Corrado Betterle; Decio Armanini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

Review 5.  Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy.

Authors:  Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin; Gabriella Donà; Jacopo Manso; Filippo Ceccato; Carla Scaroni; Decio Armanini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-23       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.